Mark W. Leuchtenberger
|Age||Total Calculated Compensation||This person is connected to 17 board members in 3 different organizations across 7 different industries.|
See Board Relationships
Mr. Mark W. Leuchtenberger is a Co-Founder of Albor Biologics, Inc. and Alvos Therapeutics, Inc. Mr. Leuchtenberger served as Chief Executive Officer of Chiasma, Inc. from March 2015 to October 1, 2016 and served as its President from March 2015 to April 12, 2016. He served as the Chief Executive Officer and President of Acusphere, Inc., since September 2013. He served as the President of Melinta Therapeutics, Inc. since March 23, 2010 and served as its Chief Executive ...
300 George StreetPhone: 203-624-5606
New Haven, Connecticut 06511-6663
Board Members Memberships*
Wake Forest University
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|There is no Competitor Compensation data available.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.